<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Welch</surname>
    <given-names>S. R.</given-names>
   </name>
   <name>
    <surname>Scholte</surname>
    <given-names>F. E. M.</given-names>
   </name>
   <name>
    <surname>Flint</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chatterjee</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Nichol</surname>
    <given-names>S. T.</given-names>
   </name>
   <name>
    <surname>Bergeron</surname>
    <given-names>É.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2017</year>). 
  <article-title>Identification of 2′-deoxy-2′-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus</article-title>. 
  <source>Antiviral Res.</source>
  <volume>147</volume>, 
  <fpage>91</fpage>–
  <lpage>99</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.10.008</pub-id>
  <?supplied-pmid 29024765?>
  <pub-id pub-id-type="pmid">29024765</pub-id>
 </mixed-citation>
</ref>
